International multidisciplinary team discussions on the diagnosis of idiopathic non-specific interstitial pneumonia and the development of connective tissue disease
- PMID: 34178296
- PMCID: PMC8205078
- DOI: 10.1080/20018525.2021.1933878
International multidisciplinary team discussions on the diagnosis of idiopathic non-specific interstitial pneumonia and the development of connective tissue disease
Abstract
Background: Idiopathic Non-Specific Interstitial Pneumonia (iNSIP) is a rare interstitial lung disease, diagnosed, by definition, on the basis of a multidisciplinary team discussion (MDD). Association with an autoimmune background has been suggested in iNSIP.
Aims: To test the feasibility of conducting a multinational MDD to review the diagnosis in iNSIP cases and to estimate the emergence of connective tissue disease (CTD) during follow-up.
Methods: Investigators from three expert centers (Denmark, Estonia and Norway) met and discussed cases of biopsy-proven iNSIP at an international MDD. The cases were previously diagnosed at a national level between 2004 and 2014. Based on clinical, radiographic and pathological data, the diagnosis of iNSIP was re-evaluated and a consensus diagnosis was made. Cases incompatible with iNSIP were excluded. Relevant data were registered comprising any development of CTD.
Results: In total, 31 cases were discussed and 23 patients were included with a diagnosis of iNSIP. The mean follow-up time was 57 months. None of the patients developed CTD according to the rheumatologic criteria during the follow up period. Four patients (17.4%) met the criteria for interstitial pneumonia with autoimmune features.
Conclusion: We found that an international MDD was a feasible and valuable tool in the retrospective diagnostic evaluation of iNSIP. Diagnosis was changed in a statistically significant number of patients by our international MDD team. None of the patients developed CTD during follow-up.
Keywords: Non-specific interstitial pneumonia; connective tissue disease; idiopathic pneumonia with autoimmune features; multidisciplinary team discussion.
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Conflict of interest statement
Janne Møller has received lecture fees from Roche and participated in advisory boards of Roche. Alan Altraja has received lecture fees and sponsorships from Boehringer Ingelheim and Roche and research support from Boehringer Ingelheim, and has participated in advisory boards of Boehringer Ingelheim and Roche. Elisabeth Bendstrup reports fees and grants from Boehringer Ingelheim, Hoffman la Roche, Galapagos, and Bristol-Myers-Squibb.
Figures
References
-
- International S, Consensus M.. American thoracic society American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165:277–7. - PubMed
-
- Travis WD, Hunninghake G, King TE Jr, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008;177(12):1338–1347. - PubMed
-
- Romagnoli M, Nannini C, Piciucchi S, et al. Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?. Eur Respir J. 2011;38(2):384–391. - PubMed
-
- Fischer A, Antoniou KM, Brown KK, et al. An official European respiratory society/American thoracic society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46(4):976–987. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous